• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM

IMMUTEP LIMITED - Announcements

0.00% ! 27.0¢
Market Cap $388.9M  !

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



IMM Response to ASX Aware QueryPRICE SENSITIVE18/04/23 download Created with Sketch. 906.49KB
IMM Initiation of Phase 2 Trial for Efti in Soft Tissue SarcomaPRICE SENSITIVE17/04/23 download Created with Sketch. 245.57KB
IMM Notification of cessation of securities - IMM11/04/23 download Created with Sketch. 21.53KB
IMM Appendix 3Z - Lucy Turnbull11/04/23 download Created with Sketch. 205.54KB
IMM Appendix 3X - Lis Boyce11/04/23 download Created with Sketch. 167.62KB
IMM Immutep Announces Changes to the Board11/04/23 download Created with Sketch. 210.12KB
IMM Positive Final Data in 2nd Line Metastatic NSCLC PatientsPRICE SENSITIVE31/03/23 download Created with Sketch. 283.42KB
IMM Change in substantial holding31/03/23 download Created with Sketch. 1.52MB
IMM Expansion of INSIGHT-003 trial for Efti in 1st Line NSCLCPRICE SENSITIVE30/03/23 download Created with Sketch. 251.07KB
IMM Abstract accepted for ESMO's European Lung Cancer Congress23/03/23 download Created with Sketch. 284.98KB
IMM Initiation of Ph 2/3 Trial for Metastatic Breast CancerPRICE SENSITIVE14/03/23 download Created with Sketch. 219.54KB
IMM Half Yearly Report and AccountsPRICE SENSITIVE24/02/23 download Created with Sketch. 698.94KB
IMM Enrolment Target Reached for INSIGHT-003 Trial in NSCLCPRICE SENSITIVE06/02/23 download Created with Sketch. 270.62KB
IMM Immutep Quarterly Activities Report and Appendix 4CPRICE SENSITIVE30/01/23 download Created with Sketch. 434.19KB
IMM Notification of cessation of securities - IMM06/01/23 download Created with Sketch. 21.66KB
IMM TACTI-003 trial 50% enrolment milestone has been achievedPRICE SENSITIVE04/01/23 download Created with Sketch. 246.71KB
IMM Update on MBC trial design following successful FDA meetingPRICE SENSITIVE23/12/22 download Created with Sketch. 226.76KB
IMM Change of Director's Interest Notice L Turnbull22/12/22 download Created with Sketch. 224.7KB
IMM Change of Director's Interest Notice - P Meyers22/12/22 download Created with Sketch. 218.24KB
IMM Change of Director's Interest Notice - R Howard22/12/22 download Created with Sketch. 214.28KB
IMM Application for quotation of securities - IMM21/12/22 download Created with Sketch. 24.96KB
IMM Notification regarding unquoted securities - IMM16/12/22 download Created with Sketch. 23.92KB
IMM Notification regarding unquoted securities - IMM16/12/22 download Created with Sketch. 23.94KB
IMM Proposed issue of securities - IMM15/12/22 download Created with Sketch. 25.23KB
IMM Commercial Scale in Manufacturing of Efti AchievedPRICE SENSITIVE08/12/22 download Created with Sketch. 270.09KB
IMM GMP Manufacturing Process Developed for IMP761 LAG-3 AgonistPRICE SENSITIVE06/12/22 download Created with Sketch. 279.08KB
IMM Immutep enters 2nd collaboration with Pfizer and Merck KGaAPRICE SENSITIVE29/11/22 download Created with Sketch. 235.72KB
IMM Results of Meeting23/11/22 download Created with Sketch. 259.09KB
IMM Immutep AGM 2022 - CEO's Presentation23/11/22 download Created with Sketch. 2.86MB
IMM Immutep AGM 2022 - Chairman's Address23/11/22 download Created with Sketch. 215.14KB
IMM Immutep Investor Update17/11/22 download Created with Sketch. 685.16KB
IMM Immutep receives A$1 million R&D Tax IncentivePRICE SENSITIVE14/11/22 download Created with Sketch. 211.58KB
IMM Immutep Webcast to discuss clinical data presented at SITCPRICE SENSITIVE11/11/22 download Created with Sketch. 2.15MB
IMM TACTI-002 data presented at SITC for Efti in 1st line NSCLCPRICE SENSITIVE11/11/22 download Created with Sketch. 501.15KB
IMM INSIGHT-003 triple combination data presented at SITC 2022PRICE SENSITIVE11/11/22 download Created with Sketch. 302.49KB
IMM New Patents Granted in Japan and South Korea for EftiPRICE SENSITIVE09/11/22 download Created with Sketch. 221.41KB
IMM Abstract for Efti selected for SITC 2022 Press Conference04/11/22 download Created with Sketch. 276.74KB
IMM Late Breaking Abstract accepted for SITC Oral PresentationPRICE SENSITIVE03/11/22 download Created with Sketch. 203.62KB
IMM Immutep Corporate Presentation02/11/22 download Created with Sketch. 3.35MB
IMM Immutep to Participate in Two Upcoming Investor Conferences02/11/22 download Created with Sketch. 202.17KB
IMM Annual Report filed on Form 20-F with SEC01/11/22 download Created with Sketch. 723.33KB
IMM Change of Registry Address31/10/22 download Created with Sketch. 77.61KB
IMM Independent DMC recommends to continue TACTI-003 as plannedPRICE SENSITIVE26/10/22 download Created with Sketch. 220.03KB
IMM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE25/10/22 download Created with Sketch. 436.35KB
IMM Notice of Annual General Meeting/Proxy Form21/10/22 download Created with Sketch. 1.96MB
IMM Appendix 4G and Corporate Governance Statement21/10/22 download Created with Sketch. 507.72KB
IMM Annual Report to shareholders21/10/22 download Created with Sketch. 1.15MB
IMM Change in substantial holding18/10/22 download Created with Sketch. 1.52MB
IMM Application for quotation of securities - IMM13/10/22 download Created with Sketch. 24.9KB
IMM Ceasing to be a substantial shareholder from AEF06/10/22 download Created with Sketch. 208.7KB
IMM Abstracts accepted for Presentation at SITC 2022PRICE SENSITIVE06/10/22 download Created with Sketch. 281.18KB
IMM Change of Director's Interest Notice - P Meyers05/10/22 download Created with Sketch. 222.81KB
IMM Change of Director's Interest Notice - M Voigt05/10/22 download Created with Sketch. 216.36KB
IMM Change of Director's Interest Notice - F Triebel05/10/22 download Created with Sketch. 210.62KB
IMM Fast Track granted by US FDA for Efti in 1st line NSCLCPRICE SENSITIVE04/10/22 download Created with Sketch. 219.24KB
IMM Application for quotation of securities - IMM03/10/22 download Created with Sketch. 25.91KB
IMM Becoming a substantial holder from AEF30/09/22 download Created with Sketch. 234.8KB
IMM Immutep to Participate in Two Upcoming Investor Conferences26/09/22 download Created with Sketch. 192.56KB
IMM Immutep Receives A$2.7 million R&D French Tax IncentivePRICE SENSITIVE23/09/22 download Created with Sketch. 224.2KB
IMM 2022 AGM & Key Dates21/09/22 download Created with Sketch. 207.65KB
IMM Clinical Development Update for Eftilagimod AlphaPRICE SENSITIVE14/09/22 download Created with Sketch. 266.4KB
IMM Initial Director's Interest Notice - Frederic Triebel13/09/22 download Created with Sketch. 173.02KB
IMM Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board13/09/22 download Created with Sketch. 210.91KB
IMM New investigator-initiated ph2 trial in Soft Tissue SarcomaPRICE SENSITIVE06/09/22 download Created with Sketch. 261.11KB
IMM Appendix 4E & 2022 Full Year Statutory AccountsPRICE SENSITIVE31/08/22 download Created with Sketch. 1.41MB
IMM Japanese Patent Grant for efti, soluble LAG-3 with anti-PD-1PRICE SENSITIVE30/08/22 download Created with Sketch. 205.5KB
IMM TACTI-002 2nd line lung cancer data presented at 2022 WCLCPRICE SENSITIVE01/08/22 download Created with Sketch. 351.3KB
IMM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/07/22 download Created with Sketch. 491.51KB
IMM Notification of cessation of securities - IMM14/07/22 download Created with Sketch. 21.59KB
IMM Immutep granted Japanese Patent for IMP761PRICE SENSITIVE06/07/22 download Created with Sketch. 212.66KB
IMM TACTI-002 lung cancer data to be presented at 2022 WCLC27/06/22 download Created with Sketch. 279.96KB
IMM Immutep Investor Update17/06/22 download Created with Sketch. 680.08KB
IMM Webcast slides for 1st line NSCLC data from TACTI-002 trialPRICE SENSITIVE06/06/22 download Created with Sketch. 1.08MB
IMM Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trialPRICE SENSITIVE06/06/22 download Created with Sketch. 400.36KB
IMM Immutep webcast for TACTI-002 data presented at ASCO 202202/06/22 download Created with Sketch. 224.83KB
IMM Immutep announces publication of ASCO 2022 abstractsPRICE SENSITIVE27/05/22 download Created with Sketch. 269.28KB
IMM Immutep Corporate Presentation24/05/22 download Created with Sketch. 1.55MB
IMM Immutep to Present at Investor Conferences20/05/22 download Created with Sketch. 219.12KB
IMM Leading Oncologists appointed to Clinical Advisory Board18/05/22 download Created with Sketch. 216.59KB
IMM New & significant data from AIPAC phase 2b trial in MBCPRICE SENSITIVE04/05/22 download Created with Sketch. 305.97KB
IMM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/04/22 download Created with Sketch. 509.1KB
IMM Immutep to announce new TACTI-002 data at ASCO 2022PRICE SENSITIVE28/04/22 download Created with Sketch. 279.77KB
IMM Change in substantial holding08/04/22 download Created with Sketch. 1.21MB
IMM Efti with Keytruda shows encouraging activity in lung cancerPRICE SENSITIVE30/03/22 download Created with Sketch. 330.5KB
IMM Immutep announces publication of ELCC 2022 abstractPRICE SENSITIVE24/03/22 download Created with Sketch. 270.86KB
IMM Immutep to present Phase IIb breast cancer data at ESMO 202218/03/22 download Created with Sketch. 257.89KB
IMM Japanese patent granted for LAG-3 antibody LAG525PRICE SENSITIVE18/03/22 download Created with Sketch. 215.79KB
IMM Change in substantial holding16/03/22 download Created with Sketch. 922.9KB
IMM Application for quotation of securities - IMM11/03/22 download Created with Sketch. 24.91KB
IMM Immutep receives FDA feedback for Efti development in MBCPRICE SENSITIVE10/03/22 download Created with Sketch. 212.58KB
IMM Initial Director's Interest Notice - Lucy Turnbull25/02/22 download Created with Sketch. 217.9KB
IMM Proposed issue of securities - IMM25/02/22 download Created with Sketch. 24.96KB
IMM Appointment of Non-Executive Director25/02/22 download Created with Sketch. 200.93KB
IMM Immutep to Present at Healthcare Investor Conferences24/02/22 download Created with Sketch. 217.16KB
IMM Half Yearly Report and AccountsPRICE SENSITIVE23/02/22 download Created with Sketch. 479.99KB
IMM Immutep to present new data from TACTI-002 at ELCC 202218/02/22 download Created with Sketch. 258.5KB
IMM Immutep Investor Update18/02/22 download Created with Sketch. 1.22MB
IMM Australian Patent Granted for Efti with PD-1 InhibitorsPRICE SENSITIVE11/02/22 download Created with Sketch. 225.18KB
IMM Change in substantial holding02/02/22 download Created with Sketch. 1.21MB
IMM Death of Director Grant Chamberlain02/02/22 download Created with Sketch. 447.75KB
IMM Response to ASX Aware Query
18/04/23PRICE SENSITIVE download Created with Sketch. 906.49KB
IMM Initiation of Phase 2 Trial for Efti in Soft Tissue Sarcoma
17/04/23PRICE SENSITIVE download Created with Sketch. 245.57KB
IMM Notification of cessation of securities - IMM
11/04/23 download Created with Sketch. 21.53KB
IMM Appendix 3Z - Lucy Turnbull
11/04/23 download Created with Sketch. 205.54KB
IMM Appendix 3X - Lis Boyce
11/04/23 download Created with Sketch. 167.62KB
IMM Immutep Announces Changes to the Board
11/04/23 download Created with Sketch. 210.12KB
IMM Positive Final Data in 2nd Line Metastatic NSCLC Patients
31/03/23PRICE SENSITIVE download Created with Sketch. 283.42KB
IMM Change in substantial holding
31/03/23 download Created with Sketch. 1.52MB
IMM Expansion of INSIGHT-003 trial for Efti in 1st Line NSCLC
30/03/23PRICE SENSITIVE download Created with Sketch. 251.07KB
IMM Abstract accepted for ESMO's European Lung Cancer Congress
23/03/23 download Created with Sketch. 284.98KB
IMM Initiation of Ph 2/3 Trial for Metastatic Breast Cancer
14/03/23PRICE SENSITIVE download Created with Sketch. 219.54KB
IMM Half Yearly Report and Accounts
24/02/23PRICE SENSITIVE download Created with Sketch. 698.94KB
IMM Enrolment Target Reached for INSIGHT-003 Trial in NSCLC
06/02/23PRICE SENSITIVE download Created with Sketch. 270.62KB
IMM Immutep Quarterly Activities Report and Appendix 4C
30/01/23PRICE SENSITIVE download Created with Sketch. 434.19KB
IMM Notification of cessation of securities - IMM
06/01/23 download Created with Sketch. 21.66KB
IMM TACTI-003 trial 50% enrolment milestone has been achieved
04/01/23PRICE SENSITIVE download Created with Sketch. 246.71KB
IMM Update on MBC trial design following successful FDA meeting
23/12/22PRICE SENSITIVE download Created with Sketch. 226.76KB
IMM Change of Director's Interest Notice L Turnbull
22/12/22 download Created with Sketch. 224.7KB
IMM Change of Director's Interest Notice - P Meyers
22/12/22 download Created with Sketch. 218.24KB
IMM Change of Director's Interest Notice - R Howard
22/12/22 download Created with Sketch. 214.28KB
IMM Application for quotation of securities - IMM
21/12/22 download Created with Sketch. 24.96KB
IMM Notification regarding unquoted securities - IMM
16/12/22 download Created with Sketch. 23.92KB
IMM Notification regarding unquoted securities - IMM
16/12/22 download Created with Sketch. 23.94KB
IMM Proposed issue of securities - IMM
15/12/22 download Created with Sketch. 25.23KB
IMM Commercial Scale in Manufacturing of Efti Achieved
08/12/22PRICE SENSITIVE download Created with Sketch. 270.09KB
IMM GMP Manufacturing Process Developed for IMP761 LAG-3 Agonist
06/12/22PRICE SENSITIVE download Created with Sketch. 279.08KB
IMM Immutep enters 2nd collaboration with Pfizer and Merck KGaA
29/11/22PRICE SENSITIVE download Created with Sketch. 235.72KB
IMM Results of Meeting
23/11/22 download Created with Sketch. 259.09KB
IMM Immutep AGM 2022 - CEO's Presentation
23/11/22 download Created with Sketch. 2.86MB
IMM Immutep AGM 2022 - Chairman's Address
23/11/22 download Created with Sketch. 215.14KB
IMM Immutep Investor Update
17/11/22 download Created with Sketch. 685.16KB
IMM Immutep receives A$1 million R&D Tax Incentive
14/11/22PRICE SENSITIVE download Created with Sketch. 211.58KB
IMM Immutep Webcast to discuss clinical data presented at SITC
11/11/22PRICE SENSITIVE download Created with Sketch. 2.15MB
IMM TACTI-002 data presented at SITC for Efti in 1st line NSCLC
11/11/22PRICE SENSITIVE download Created with Sketch. 501.15KB
IMM INSIGHT-003 triple combination data presented at SITC 2022
11/11/22PRICE SENSITIVE download Created with Sketch. 302.49KB
IMM New Patents Granted in Japan and South Korea for Efti
09/11/22PRICE SENSITIVE download Created with Sketch. 221.41KB
IMM Abstract for Efti selected for SITC 2022 Press Conference
04/11/22 download Created with Sketch. 276.74KB
IMM Late Breaking Abstract accepted for SITC Oral Presentation
03/11/22PRICE SENSITIVE download Created with Sketch. 203.62KB
IMM Immutep Corporate Presentation
02/11/22 download Created with Sketch. 3.35MB
IMM Immutep to Participate in Two Upcoming Investor Conferences
02/11/22 download Created with Sketch. 202.17KB
IMM Annual Report filed on Form 20-F with SEC
01/11/22 download Created with Sketch. 723.33KB
IMM Change of Registry Address
31/10/22 download Created with Sketch. 77.61KB
IMM Independent DMC recommends to continue TACTI-003 as planned
26/10/22PRICE SENSITIVE download Created with Sketch. 220.03KB
IMM Quarterly Activities/Appendix 4C Cash Flow Report
25/10/22PRICE SENSITIVE download Created with Sketch. 436.35KB
IMM Notice of Annual General Meeting/Proxy Form
21/10/22 download Created with Sketch. 1.96MB
IMM Appendix 4G and Corporate Governance Statement
21/10/22 download Created with Sketch. 507.72KB
IMM Annual Report to shareholders
21/10/22 download Created with Sketch. 1.15MB
IMM Change in substantial holding
18/10/22 download Created with Sketch. 1.52MB
IMM Application for quotation of securities - IMM
13/10/22 download Created with Sketch. 24.9KB
IMM Ceasing to be a substantial shareholder from AEF
06/10/22 download Created with Sketch. 208.7KB
IMM Abstracts accepted for Presentation at SITC 2022
06/10/22PRICE SENSITIVE download Created with Sketch. 281.18KB
IMM Change of Director's Interest Notice - P Meyers
05/10/22 download Created with Sketch. 222.81KB
IMM Change of Director's Interest Notice - M Voigt
05/10/22 download Created with Sketch. 216.36KB
IMM Change of Director's Interest Notice - F Triebel
05/10/22 download Created with Sketch. 210.62KB
IMM Fast Track granted by US FDA for Efti in 1st line NSCLC
04/10/22PRICE SENSITIVE download Created with Sketch. 219.24KB
IMM Application for quotation of securities - IMM
03/10/22 download Created with Sketch. 25.91KB
IMM Becoming a substantial holder from AEF
30/09/22 download Created with Sketch. 234.8KB
IMM Immutep to Participate in Two Upcoming Investor Conferences
26/09/22 download Created with Sketch. 192.56KB
IMM Immutep Receives A$2.7 million R&D French Tax Incentive
23/09/22PRICE SENSITIVE download Created with Sketch. 224.2KB
IMM 2022 AGM & Key Dates
21/09/22 download Created with Sketch. 207.65KB
IMM Clinical Development Update for Eftilagimod Alpha
14/09/22PRICE SENSITIVE download Created with Sketch. 266.4KB
IMM Initial Director's Interest Notice - Frederic Triebel
13/09/22 download Created with Sketch. 173.02KB
IMM Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board
13/09/22 download Created with Sketch. 210.91KB
IMM New investigator-initiated ph2 trial in Soft Tissue Sarcoma
06/09/22PRICE SENSITIVE download Created with Sketch. 261.11KB
IMM Appendix 4E & 2022 Full Year Statutory Accounts
31/08/22PRICE SENSITIVE download Created with Sketch. 1.41MB
IMM Japanese Patent Grant for efti, soluble LAG-3 with anti-PD-1
30/08/22PRICE SENSITIVE download Created with Sketch. 205.5KB
IMM TACTI-002 2nd line lung cancer data presented at 2022 WCLC
01/08/22PRICE SENSITIVE download Created with Sketch. 351.3KB
IMM Quarterly Activities/Appendix 4C Cash Flow Report
28/07/22PRICE SENSITIVE download Created with Sketch. 491.51KB
IMM Notification of cessation of securities - IMM
14/07/22 download Created with Sketch. 21.59KB
IMM Immutep granted Japanese Patent for IMP761
06/07/22PRICE SENSITIVE download Created with Sketch. 212.66KB
IMM TACTI-002 lung cancer data to be presented at 2022 WCLC
27/06/22 download Created with Sketch. 279.96KB
IMM Immutep Investor Update
17/06/22 download Created with Sketch. 680.08KB
IMM Webcast slides for 1st line NSCLC data from TACTI-002 trial
06/06/22PRICE SENSITIVE download Created with Sketch. 1.08MB
IMM Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial
06/06/22PRICE SENSITIVE download Created with Sketch. 400.36KB
IMM Immutep webcast for TACTI-002 data presented at ASCO 2022
02/06/22 download Created with Sketch. 224.83KB
IMM Immutep announces publication of ASCO 2022 abstracts
27/05/22PRICE SENSITIVE download Created with Sketch. 269.28KB
IMM Immutep Corporate Presentation
24/05/22 download Created with Sketch. 1.55MB
IMM Immutep to Present at Investor Conferences
20/05/22 download Created with Sketch. 219.12KB
IMM Leading Oncologists appointed to Clinical Advisory Board
18/05/22 download Created with Sketch. 216.59KB
IMM New & significant data from AIPAC phase 2b trial in MBC
04/05/22PRICE SENSITIVE download Created with Sketch. 305.97KB
IMM Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22PRICE SENSITIVE download Created with Sketch. 509.1KB
IMM Immutep to announce new TACTI-002 data at ASCO 2022
28/04/22PRICE SENSITIVE download Created with Sketch. 279.77KB
IMM Change in substantial holding
08/04/22 download Created with Sketch. 1.21MB
IMM Efti with Keytruda shows encouraging activity in lung cancer
30/03/22PRICE SENSITIVE download Created with Sketch. 330.5KB
IMM Immutep announces publication of ELCC 2022 abstract
24/03/22PRICE SENSITIVE download Created with Sketch. 270.86KB
IMM Immutep to present Phase IIb breast cancer data at ESMO 2022
18/03/22 download Created with Sketch. 257.89KB
IMM Japanese patent granted for LAG-3 antibody LAG525
18/03/22PRICE SENSITIVE download Created with Sketch. 215.79KB
IMM Change in substantial holding
16/03/22 download Created with Sketch. 922.9KB
IMM Application for quotation of securities - IMM
11/03/22 download Created with Sketch. 24.91KB
IMM Immutep receives FDA feedback for Efti development in MBC
10/03/22PRICE SENSITIVE download Created with Sketch. 212.58KB
IMM Initial Director's Interest Notice - Lucy Turnbull
25/02/22 download Created with Sketch. 217.9KB
IMM Proposed issue of securities - IMM
25/02/22 download Created with Sketch. 24.96KB
IMM Appointment of Non-Executive Director
25/02/22 download Created with Sketch. 200.93KB
IMM Immutep to Present at Healthcare Investor Conferences
24/02/22 download Created with Sketch. 217.16KB
IMM Half Yearly Report and Accounts
23/02/22PRICE SENSITIVE download Created with Sketch. 479.99KB
IMM Immutep to present new data from TACTI-002 at ELCC 2022
18/02/22 download Created with Sketch. 258.5KB
IMM Immutep Investor Update
18/02/22 download Created with Sketch. 1.22MB
IMM Australian Patent Granted for Efti with PD-1 Inhibitors
11/02/22PRICE SENSITIVE download Created with Sketch. 225.18KB
IMM Change in substantial holding
02/02/22 download Created with Sketch. 1.21MB
IMM Death of Director Grant Chamberlain
02/02/22 download Created with Sketch. 447.75KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
27.0¢
Change
0.000(0.00%)
Mkt cap ! $388.9M
Open High Low Value Volume
27.5¢ 27.5¢ 26.5¢ $144.0K 533.6K

Buyers (Bids)

No. Vol. Price($)
17 465740 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 202348 22
View Market Depth
Last trade - 11.29am 11/08/2025 (20 minute delay) ?
Last
26.8¢
  Change
0.000 ( 2.55 %)
Open High Low Volume
27.5¢ 27.5¢ 26.5¢ 398268
Last updated 11.45am 11/08/2025 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.